MedTrace Logo

Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants

NCT05285735 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2024-01-30

No results posted yet for this study

Summary

This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.

Conditions

Sponsors & Collaborators

  • Amivas Inc.

    lead INDUSTRY

Principal Investigators

  • Bryan Smith, MD · Amivas Inc.

Eligibility

Min Age
15 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2029-06-08
Completion
2029-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05285735 on ClinicalTrials.gov